Concepedia
Statistics
Publications
4
Citations
110
H-Index
Active since
2006
Affiliations
Pfizer (United States)(Current)
Johnson & Johnson (United States)
Maria Gavriil is an author at Pfizer (United States) specializing in molecular oncology, oncology, and pharmacology.
Publications per year
2006–2017
A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in mice
Timothy S. Fisher, Andrea T. Hooper, Justin Lucas et al. · Cancer Immunology Immunotherapy · 2017 · 41 citations · Full text
Medicine, Immunology, Oncology +11
Combination therapy for treating breast cancer using antiestrogen, ERA-923, and the mammalian target of rapamycin inhibitor, temsirolimus
Tyler Sadler, Maria Gavriil, Tami Annable et al. · Endocrine Related Cancer · 2006 · 38 citations · Full text
Medicine, Oncology, Pharmacology +15
Synthesis and biological evaluation of tricyclic anilinopyrimidines as IKKβ inhibitors
Aimee L. Crombie, Fuk‐Wah Sum, Dennis Powell et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 16 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +12
IκBα Kinase Inhibitor IKI-1 Conferred Tumor Necrosis Factor α Sensitivity to Pancreatic Cancer Cells and a Xenograft Tumor Model
Yixian Zhang, Maria Gavriil, Judy Lucas et al. · Cancer Research · 2008 · 15 citations · Full text
Life Sciences, Oncology, Pharmacology +17
1–4 of 4